ClinicalTrials.gg
CompletedNCT00505609Updated Jul 23, 2007

Efficacy of the Standard Days Method of Family Planning

An interventional study of Standard Days Method in Women's Health, sponsored by Georgetown University. Completed at 3 sites in 3 countries. Open to female participants aged 18 Years to 39 Years. Per ClinicalTrials.gov, last updated 2007-07-23.

Sponsored by Georgetown University · Not applicable and Interventional

Phase
Not applicable
Study type
Interventional
Enrollment
478
Allocation
Non-randomized
Ages
18 Years to 39 Years
Sex
Female
01

Study summary

The Standard Days Method® is a fertility awareness-based method of family planning in which users avoid unprotected intercourse during cycle day 8 through 19. The method is most appropriate for women with cycles that usually range 26-32 days. The clinical trial tested the contraceptive efficacy of the Standard Days Method. A total of 478 women, age 18-39 years, in Bolivia, Peru, and the Philippines, with self-reported cycles of 26-32 days, desiring to delay pregnancy at least one year were admitted to the study and followed for up to 13 cycles of method use.

Read the detailed description

The Standard Days Method® is a fertility awareness-based method of family planning. Users avoid unprotected intercourse during cycle day 8 through cycle day 19. The method is most effective for women with cycles that usually range 26-32 days. It was developed by applying various formulae (i.e. various numbers of days and various sets of days) to over 7500 menstrual cycles in an existing data set from the World Health Organization, to determine which formula would provide the optimal balance between he length of the identified fertile period and the efficacy in avoiding unplanned pregnancy.

The purpose of the clinical trial was to test the efficacy of the method in preventing pregnancy.

Participants were from five sites in Bolivia, Peru, and the Philippines. In all sites, the Institute for Reproductive Health trained 5-10 health workers (service providers) in teaching the Standard Days Method to study subjects and in study procedures. Method provision involved a counseling session in which the woman (or the couple, if her partner was available) was instructed in the use of the method, and counseled on the importance of following the method recommendations to avoid pregnancy.

To assist women in monitoring their cycles, the provider gave them CycleBeads® a mnemonic device, a string of 32 beads in which each beads represents a day of the menstrual cycle. The first bead is red, representing the first day of menses; the next 6 beads are brown, representing the additional non-fertile days preceding the fertile window; the next 12 beads are white, representing days that should be considered fertile (8-19); and the remaining 13 beads are brown, again representing non-fertile days. It also has a moveable, tight-fitting rubber ring that is used to mark the current day of the cycle. Women were instructed to place the ring on the red bead on the day their menses began, and move the ring one bead per day until their menses returned. They also were told that to avoid pregnancy they should not have unprotected intercourse on the days the ring was on a white bead. If they had menstrual bleeding before day 27 of the cycle (i.e., a cycle shorter than 26 days), or if their menses had not occurred by the day after they completed all 32 beads (i.e., a cycle longer than 32 days), they were instructed to contact their provider for further assessment and advice. Women who had two cycles outside the 26 through 32 day range during the study period were advised to use another method, and were withdrawn from the study.

A total of 478 women wishing to use the Standard Days Method and meeting the eligibility criteria were admitted to the study after signing an informed consent form and interviewed monthly until they either completed 13 cycles of method use or left the study for other reasons. The first level of data collection was administered by the clients themselves. Each woman was asked to keep a daily diary to record menstrual bleeding, intercourse, and use of any other contraceptive method. The information on the diary card was reviewed by the clients and the service provider during each of the monthly follow-up contacts. In addition, follow-up forms were administered, which included questions concerning method use, satisfaction, and willingness to continue in the study.

Women who had not had their menses by day 42 of their cycle were tested for pregnancy. If results were negative, they were followed until they tested positive or their menses returned. Loss to follow-up was minimized by interviewing study participants in their homes and actively seeking out each participant, with a minimum of three attempts per cycle.

Single-decrement multi-censoring life tables were used to calculate pregnancy rates.

02

Conditions studied

  • Women's Health

Keywords

  • fertility awareness-based method
  • family planning
  • Standard Days Method
  • Institute for Reproductive Health
  • Efficacy
  • CycleBeads
03

In context

Lead sponsor

Georgetown University is the lead sponsor of 291 studies on the registry; 41 are open to participants now.

Of its 28 completed or terminated interventional studies of FDA-regulated products, 20 (71%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 39 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Women
  • Age 18-39
  • Married or living with stable partner
  • At least three cycles (four periods) since last birth
  • Self reported cycles 26-32 days long
  • Willing to avoid intercourse 12 consecutive days every cycle
  • Partners willing to collaborate
  • No known infertility problems
  • Not at risk for sexually transmitted infections
  • No contraindications of pregnancy
  • No use of hormonal contraceptives in three months prior to admission
  • Desiring to avoid pregnancy for at least one year

Exclusion criteria

Exclusion Criteria:

  • Women who have cycles outside of the 26-32 day range
  • Women/couples not interested in the method
  • Women who have not yet had 3 regular cycles after childbirth
  • Women who have used hormonal contraceptives in the previous 3 months
  • Those women at risk for sexual transmitted infections
  • Women/couples who cannot manage the fertile days by avoiding intercourse or using a barrier method
05

Study design

Phase
Not applicable
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
478 participants (actual)

Study arms

  • Experimental
    A

    The Institute for Reproductive Health trained health providers in teaching the Standard Days Method to study subjects and in study procedures. Providers counseled study participants in method use. Participants were followed for up to 13 cycles of method use.

    Behavioral: Standard Days Method

Interventions

  • BehavioralStandard Days Method

    The Standard Days Method is a fertility awareness-based method of family planning. Users avoid unprotected intercourse during cycle days 8 to 19. Study participants were for up to 13 cycles of method use.

    Also known as: CycleBeads

06

What researchers measure

Primary outcomes

  1. Pregnancy rate with correct method use

    Time frame: 1 year (13 cycles)

Secondary outcomes

  1. Pregnancy rate with typical method use

    Time frame: 1 year (13 cycles)

07

Study locations

3 sites
  • Institute for Reproductive Health, Bolivia
    La Paz, Sopocachi 243, Bolivia
  • Instituto de Salud Reporductiva
    Lima, La Molina 1885, Peru
  • Institute for Reproductive Health, Philippines
    Quezon City, Loyola Heights 1108, Philippines
08

References and documents

Publications

  • Arevalo M, Jennings V, Sinai I. Efficacy of a new method of family planning: the Standard Days Method. Contraception. 2002 May;65(5):333-8. doi: 10.1016/s0010-7824(02)00288-3. PubMed 12057784 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 23, 2007, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00505609
Collaborators
United States Agency for International Development (USAID)
First posted
Jul 23, 2007
Start date
Nov 1999
Completion
Oct 2001
Last update
Jul 23, 2007

Study contacts

Victoria H. Jennings, PhD
principal investigator · Georgetown University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2007. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion